Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 16

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 16
---
 faith judgment of our management, such statements can only be based
on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties
and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking
statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically
addressed under the heading “Risk Factors” contained in this prospectus supplement, the accompanying prospectus and any related
free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus supplement
and the accompanying prospectus, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as any
amendments thereto reflected in subsequent filings with the SEC. Readers are urged not to place undue reliance on these forward-looking
statements, which speak only as of the date made. We file reports with the SEC, and our electronic filings with the SEC (including our
Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and any amendments to these reports) are
available free of charge on the SEC’s website at http://www.sec.gov.

We undertake no obligation
to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this
prospectus supplement, except as required by law. Readers are urged to carefully review and consider the various disclosures made throughout
the entirety of this prospectus supplement, the accompanying prospectus and any related free writing prospectus, and the documents incorporated
by reference into this prospectus supplement and the accompanying prospectus, which disclosures are designed to advise interested parties
of the risks and factors that may affect our business, financial condition, results of operations and prospects.

<div align='center'>8

USE OF PROCEEDS</div>

We are filing the registration
statement of which this prospectus forms a part to permit the holders of the Shares of our Common Stock described in the section entitled
“Selling Stockholders” to resell such Shares. We are not selling any securities under this prospectus, and we will not receive
any proceeds from the sale or other disposition of shares of our Common Stock held by the selling stockholders. However, we may receive
proceeds from any exercise of the Pre-Funded Warrants or the Series A Warrants to purchase Common Stock for